Sizes of these terms reflect their relevance to your search.
Having shown preclinical promise, the first clinical data are now in on natural killer cells equipped with a chimeric antigen receptor targeting CD19. Albeit in a small number of patients so far, the experimental immunotherapy has elicited a high response rate with little to no toxicity. ©2020 American Association for Cancer Research.
Citation
Cancer Immunotherapy: Make Way for CAR NK. Cancer discovery. 2020 Apr;10(4):484
Mesh Tags
Substances
PMID: 32086314
View Full Text
